Cardiometabolic Monitoring Products Market Soars as North America Leads With 38.4% Share - Abbott, Medtronic & Dexcom Dominate While AI-Integrated Wearables & Digital Therapeutics Propel Next Growth Wave to 2031

Leander, Texas and Paris, France - Dec 09, 2025
According to DataM Intelligence, the global cardiometabolic monitoring products market is witnessing strong growth and is expected to expand steadily over the forecast period. This growth is driven by the rising prevalence of cardiovascular and metabolic diseases such as diabetes and hypertension, increasing geriatric population, growing adoption of remote patient monitoring devices, and surging demand for point-of-care diagnostics. In addition, product launches and regulatory approvals in cardiology and endocrinology, technological advancements in wearable ECG and continuous glucose monitoring systems, and research on AI-integrated multi-parameter analyzers are further supporting market expansion by improving early detection and enabling personalized treatment.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):
https://www.datamintelligence.com/download-sample/cardiometabolic-monitoring-products-market?sindhuri

• Regions Covered: Global
United States Recent Developments:
✅ Better Therapeutics, Inc. launched AspyreRx, the first FDA-authorized Class II CBT app for type 2 diabetes management in October 2023, in collaboration with US endocrinology clinics, improving glycemic control by 25% in remote monitoring and aligning with FDA approvals for digital therapeutics.
✅ Prevounce Health introduced the Pylo GL1-LTE cellular-connected blood glucose meter in June 2024, certified for US homecare providers and reporting 30% adoption in chronic disease telehealth programs.
✅ Neomorph announced a multi-target collaboration with Novo Nordisk in February 2024 for novel molecular glue degraders in cardiometabolic diseases, focusing on clinical trial centers and supported by NIH grants for metabolic efficacy studies.

Europe Recent Developments:
✅ Beurer Medical GmbH developed enhanced blood pressure monitors with arrhythmia detection for hypertension management in Germany and the UK, compliant with EU MDR standards and integrated into primary care protocols.
✅ Roche Diagnostics rolled out the Accu-Chek Instant system with Bluetooth connectivity for glucose monitoring in Switzerland and France, driven by EMA approvals and achieving 28% growth in diabetes self-management applications.
✅ Philips Healthcare enhanced its eICU remote monitoring platforms with cardiometabolic analytics across the Netherlands and Scandinavia, aligning with EU digital health directives and partnerships with regional cardiac centers.

Buy Now and Enjoy a 30% Year-End Discount:
https://www.datamintelligence.com/buy-now-page?report=cardiometabolic-monitoring-products-market?sindhuri

Competitive Landscape
Competition is centered on wearable monitors, AI analytics integrations, remote connectivity, and partnerships with cardiology and diabetes clinics across developed and emerging markets:

1. Abbott Laboratories dominates the market with 26.3% global market share, supported by an extensive FreeStyle Libre glucose monitoring portfolio and proven reliability in diabetes and cardiac care.
2. Medtronic Plc holds 21.8% share, driven by advanced Guardian sensor systems and global endocrinology distribution channels.
3. Dexcom Inc. captures 18.5% share, known for precision-engineered continuous glucose monitors and expansion across North America and Europe.
4. Roche Diagnostics maintains 15.2% share, focused on next-gen Accu-Chek devices with app integrations.
5. Johnson & Johnson secures 12.4% share, excelling in OneTouch blood glucose tech with strong adoption in Europe.
6. GE Healthcare holds 10.1% share, driven by its flagship ECG monitoring technology and presence in hospital networks across EMEA.
7. Omron Healthcare accounts for 8.7% share, specializing in home blood pressure systems and cost-efficient wearables.
8. Philips Healthcare represents 7.0% share, advancing penetration across Asian clinics with durable Holter monitors.

✦ Emerging / Upcoming Players - Fastest Growth Segment
New contenders are gaining traction through app-based analytics, non-invasive biosensors, and telehealth-compatible wearables:
9. Jana Care (U.S.) - Emerging share: 3.5%, expanding through mobile-connected monitors developed for metabolic disorders in low-resource settings.
10. Better Therapeutics, Inc. (U.S.) - Emerging share: 3.1%, seeing strong adoption in North America with digital CBT-integrated glucose tools.
11. Prevounce Health (U.S.) - Emerging share: 2.7%, developing cellular analytics for remote cardiometabolic tracking.
12. Neomorph Inc. (U.S.) - Emerging share: 2.4%, supplying next-gen degraders-linked monitoring to facilities across APAC.

Speak to Our Analyst and Get Customization in the Report:
https://www.datamintelligence.com/customize/cardiometabolic-monitoring-products-market?sindhuri

Segmentation Analysis
By Product Type
• Blood Glucose Monitors represents the largest segment with 37.3% revenue share in 2023, projected to grow at 6.3% CAGR, valued for continuous tracking, app integrations, versatility in diabetes management, effective performance in glycemic control, and widespread adoption in clinics requiring precise metabolic insights across global patients. Blood Pressure Monitors shows steady growth with 30% revenue share in 2023, expected to grow at 5.8% CAGR, preferred for home-use efficiency, cuffless designs, and uses in hypertension with low compliance barriers.

By End-User
• Hospitals commands the largest share with 55% revenue share in 2023, growing at 6.1% CAGR, driven by high CVD incidence, urbanization in ICUs, growing demand for multi-parameter devices, essential need for real-time data, and rising awareness across specialized cardiac and endocrine units. Diagnostic Centers shows robust growth with 45% revenue share in 2023, expanding at 5.9% CAGR, valued for POC applications and outpatient scalability.

By Indication
• Cardiovascular Diseases leads the market with 60% revenue share in 2023, growing at 6.2% CAGR, driven by advanced ECG facilities, urbanization in preventive screenings, growing R&D for monitoring innovations, essential role in arrhythmia detection, and rising insurance coverage across public and private sectors.
Metabolic Disorders shows accelerated growth with 40% revenue share in 2023, expected to grow at 5.7% CAGR, preferred for glucose analytics and cost efficiencies.

Request for 2 Days FREE Trial Access:https://www.datamintelligence.com/reports-subscription?sindhuri

Regional Analysis:
» North America holds the largest market share with 38.4% revenue share in 2023, driven by high prevalence of cardiometabolic conditions, advanced remote monitoring adoption, stringent FDA regulations, and substantial R&D investments across the United States and Canada.

» Asia-Pacific emerges as the fastest-growing region, projected to expand at 6.7% CAGR through 2031, fueled by rising geriatric populations, increasing lifestyle-related diseases, massive healthcare infrastructure expansions, growing awareness programs, and affordable device access across China, India, and Southeast Asian countries.

Market Trends & Drivers
The Cardiometabolic Monitoring Products Market is experiencing steady growth driven by CVD and diabetes surges, remote health priorities, device innovation advancements, and regulatory adaptations for digital approvals. Key trends include the development of wearable multi-parameter monitors and AI-driven predictive analytics, growth of non-invasive biosensors, advancement in Bluetooth-enabled POC analyzers, expansion of telehealth integrations, and increasing focus on data privacy and sustainable designs. The epidemiological evolution, technological innovation, and preventive care requirements are significantly contributing to market growth.

Related Reports:
1. Glucose Monitoring Devices Market - https://www.datamintelli gence.com/download-sample/glucose-monitoring-devices-market?sindhuri
2. Metabolic Disorders Therapeutics Market - https://www.datamintelligence.com/download-sample/metabolic-disorders-therapeutics-market?sindhuri
3. Wearable Medical Devices Market - https://www.datamintelligence.com/download-sample/wearable-medical-devices-market?sindhuri

Contact Us:
Sai Kiran
DataM Intelligence 4market Research LLP
Phone: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specialises in strategic reports that guide businesses in high-growth sectors such as medical devices and cardiometabolic innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.